NAD+ Clinical Evidence Context Most published human RCT evidence on NAD+ uses oral precursors (NR and NMN), not direct injectable NAD+
Studies in Parkinsons disease models show ghrelin, via GHS-R1a activation, reduces dopaminergic neuron loss, microglial activation, and pro-inflammatory molecules like TNF-alpha and IL-1beta
It also has anti-inflammatory properties that can help calm irritated skin, making it beneficial for conditions such as acne, rosacea, and eczema
Over time, this can result in the thinning of the hair shaft or a decrease in the number of active follicles
Stimulation of c-Src by prolactin is independent of Jak2
In this study (8) it was suggested that different IGF-1 analogs, including IGF-1 LR3, have the potential to counteract the negative action of myostatin protein, possibly helping to prevent apoptosis and protecting muscle cells